Impact of Geriatric Syndromes on Diabetes Management
Purpose of Review
In this review, we describe the components and importance of geriatric syndrome, a term describing age-related disorders coexisting in older adults with diabetes. With the aging of the population, and a higher prevalence of diabetes in older adults, we are seeing a higher prevalence of age-related conditions in older diabetes patients, resulting in high human and economic costs. Successful education and management of diabetes in older adults warrants a better understanding of these unique challenges faced by individual older adults.
Expert opinions have established the importance of recognizing geriatric syndrome and its management in older adults with diabetes. However, recent studies have shown that this approach is not yet common in patient care. Patients with significant burden of comorbidities are being treated similarly to those without this burden. Newer studies have identified individualized glycemic goals and strategies to de-intensify treatment regimens in older adults.
It is important that before forming management plans, the physical, social, and emotional/cognitive status of an older individual with diabetes are considered. In doing so, individualized goals for management of diabetes as well as other coexisting diseases can be established, leading to optimized treatment efficacy, adherence, and improved health outcomes that are relevant to the older population. The objective of this review is to raise clinician awareness of the presence of geriatric syndrome in this increasingly large patient population.
KeywordsOlder adults Geriatric syndrome Co-morbidities Diabetes management
Compliance with Ethical Standards
Conflict of Interest
Medha Munshi reports grants from Sanofi and payment as a consultant for Sanofi and Novonordisk.
Christine Slyne declares no conflict of interest.
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• Whitmer RA, Biessels GJ, Quesenberry CP, Liu JY, Karter AJ, Beeri M. Type 1 diabetes and risk of dementia in late life: the Kaiser Diabetes & Cognitive Aging Study. The Journal of the Alzheimer's Association. 2015;11:P179–80. Finds high risk of development of dementia in older adults with T1D versus those without CrossRefGoogle Scholar
- 6.Munshi MN, Riddlesworth TD, Chaytor NS, Pratley RE, Robinson B, Buse JB, Miller KM, DuBose SN, Beck RW. Cognitive Dysfunction and Hypoglycemia in Older Adults wtih Type 1 Diabetes : Results from the T1D exchange. In: American Diabetes Association; June 5-9, 2015; Boston, MA: 1481-P.Google Scholar
- 10.Cukierman-Yaffe T, Gerstein HC, Williamson JD, et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care. 2009;32:221–6.CrossRefGoogle Scholar
- 25.• Egede LE, Bishu KG, Walker RJ, Dismuke CE. Impact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004–2011. J Affect Disord. 2016;195:119–26. Discusses the high economic burden of depression and diabetes and the positive impact of proper diagnosis and treatment CrossRefGoogle Scholar
- 40.•• Williamson JD, Launer LJ, Bryan RN, et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014;174:324–33. Shows no measurable effect on cognitive decline by intensive blood pressure and lipid treatment in patients with type 2 diabetes CrossRefGoogle Scholar
- 41.•• Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175:356–62. Discusses potential overtreatment of diabetes in older adults with varying amounts of comorbidity burden from 2001-2010 CrossRefGoogle Scholar
- 42.•• Thorpe CT, Gellad WF, Good CB, et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015;38:588–95. Discusses tight gylcemic control reached in a Veterans Affair population despite the high risk for hypoglycemia, suggesting a need for de-intensification of treatment PubMedPubMedCentralGoogle Scholar
- 47.Dubowitz N, Xue W, Long Q, et al. Aging is associated with increased HbA levels, independently of glucose levels and insulin resistance, and also with decreased HbA diagnostic specificity. Diabet Med. 2014;Google Scholar